Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Non-steroidal anti-inflammatory drugs.

Gøtzsche PC.

BMJ. 2000 Apr 15;320(7241):1058-61. Review. No abstract available.

PMID:
10764369
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Non-steroidal anti-inflammatory drugs.

Gøtzsche PC.

Clin Evid. 2002 Jun;(7):1063-70. Review. No abstract available. Update in: Clin Evid. 2002 Dec;(8):1203-11.

PMID:
12230727
[PubMed - indexed for MEDLINE]
3.

Non-steroidal anti-inflammatory drugs (NSAIDs).

Day RO, Graham GG.

BMJ. 2013 Jun 11;346:f3195. doi: 10.1136/bmj.f3195. No abstract available. Erratum in: BMJ. 2013;347:f4310.

PMID:
23757736
[PubMed - indexed for MEDLINE]
4.

Use of non-steroidal anti-inflammatory drugs (NSAIDs) as immunomodulatory agents.

Fullerton JN.

BMJ. 2013 Aug 9;347:f4984. doi: 10.1136/bmj.f4984. No abstract available.

PMID:
23935082
[PubMed - indexed for MEDLINE]
6.

Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis.

Wang X, Tian HJ, Yang HK, Wanyan P, Peng YJ.

Eur J Gastroenterol Hepatol. 2011 Oct;23(10):876-80. doi: 10.1097/MEG.0b013e328349de81. Review.

PMID:
21900785
[PubMed - indexed for MEDLINE]
7.

Non-steroidal anti-inflammatory drugs.

Gøtzsche P.

Clin Evid. 2002 Dec;(8):1203-11. Review. No abstract available. Update in: Clin Evid. 2003 Jun;(9):1292-300.

PMID:
12603936
[PubMed - indexed for MEDLINE]
8.

Are rheumatoid arthritis patients more willing to accept non-steroidal anti-inflammatory drug treatment risks than osteoarthritis patients?

Bagge E, Traub M, Crotty M, Conaghan PG, Oh E, Brooks PM.

Br J Rheumatol. 1997 Apr;36(4):470-2.

PMID:
9159542
[PubMed - indexed for MEDLINE]
Free Article
9.

Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports.

Moore RA, Derry S, Makinson GT, McQuay HJ.

Arthritis Res Ther. 2005;7(3):R644-65. Epub 2005 Mar 24. Review. Erratum in: Arthritis Res Ther. 2006;8(1):401.

PMID:
15899051
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Musculoskeletal disorders. Non-steroidal anti-inflammatory drugs.

Gøtzsche PC.

Clin Evid. 2003 Jun;(9):1292-300. Review. No abstract available. Update in: Clin Evid. 2004 Jun;(11):1551-9.

PMID:
12967421
[PubMed - indexed for MEDLINE]
11.

NSAIDs questionable as first-line therapy for rheumatic conditions in the elderly.

Salach RH, Calabrese LH.

J Am Osteopath Assoc. 1994 Sep;94(9):714, 766. No abstract available.

PMID:
7995734
[PubMed - indexed for MEDLINE]
12.

[NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].

[No authors listed]

MMW Fortschr Med. 2010 May 20;152(20):46-7. German. No abstract available.

PMID:
20552882
[PubMed - indexed for MEDLINE]
13.

Selective COX-2 inhibitors.

Pasero C, McCaffery M.

Am J Nurs. 2001 Apr;101(4):55-6. No abstract available.

PMID:
11301685
[PubMed - indexed for MEDLINE]
14.

[A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].

Sigidin IaA, Pokryshkin VI.

Ter Arkh. 1987;59(4):73-6. Russian.

PMID:
2954253
[PubMed - indexed for MEDLINE]
15.

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.

Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.

PMID:
18405470
[PubMed - indexed for MEDLINE]
Free Article
16.

Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.

Watson DJ, Bolognese JA, Yu C, Krupa D, Curtis S.

Curr Med Res Opin. 2004 Dec;20(12):1899-908.

PMID:
15701208
[PubMed - indexed for MEDLINE]
17.

Osteoarthritis and rheumatoid arthritis: will new data clarify the risk:benefit ratio of cyclooxygenase-2 inhibitors?

Gogol M.

J Am Geriatr Soc. 2003 Nov;51(11):1675-6. No abstract available.

PMID:
14687407
[PubMed - indexed for MEDLINE]
18.

Oxaprozin: a new NSAID.

al-Faks MA, Pugh MC.

Orthop Rev. 1992 May;21(5):558, 560-3. Review.

PMID:
1603605
[PubMed - indexed for MEDLINE]
19.

Anti-inflammatory efficacy versus gastrointestinal safety: a dilemma resolved? Introduction.

Bach GL.

Scand J Rheumatol Suppl. 1992;96:5-6. No abstract available.

PMID:
1439625
[PubMed - indexed for MEDLINE]
20.

Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs.

van Dieten HE, Korthals-de Bos IB, van Tulder MW, Lems WF, Dijkmans BA, Boers M.

Ann Rheum Dis. 2000 Oct;59(10):753-9. Review.

PMID:
11005773
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk